Randomized Double-Blind, Placebo-Controlled, Multicenter Phase 2 Trial of Selenomethionine as a Modulator of Efficacy and Toxicity of Chemoradiation in Locally-Advanced Squamous Cell Carcinoma of the Head and Neck

M.D. Mix(Roswell Park Comprehensive Cancer Center), Michael B. Jameson(Waikato Hospital), Michael Tills(Waikato Hospital), Shiva Dibaj(Roswell Park Comprehensive Cancer Center), Adrienne Groman(Roswell Park Comprehensive Cancer Center), Wainwright Jaggernauth, Youcef M. Rustum(Roswell Park Comprehensive Cancer Center), Anurag K. Singh(Roswell Park Comprehensive Cancer Center)
International Journal of Radiation Oncology*Biology*Physics
September 20, 2013
10.1016/j.ijrobp.2013.06.1234
Cited by 4

Abstract

Related Papers

No related papers found

Powered by citation graph analysis